Provivi key facts
as of Oct 2026- Developer of insect pheromones designed to protect food supplies without toxic residues.
- Provivi is valued at approximately $420.0M as of Oct 2026 (last reported valuation).
- It has raised $248.1M across 6 recorded rounds; the latest was Early Stage VC ($25.5M) in Sep 2025.
- Notable investors include US National Science Foundation, Temasek Holdings, Gates Foundation, Vivo Capital, BASF Venture Capital — 13 tracked in total.
- 2 investment vehicles were formed to buy Provivi shares in the last 12 months, reporting $4.7M sold to 54 investors, per SEC Form D filings.
- Provivi has filed 10 Form Ds with the SEC since 2015, most recently Oct 2019 ($85.0M sold to 21 investors).
- Status: Privately Held (backing).
Provivi's last reported valuation, Mar 2021. Nothing priced has surfaced since.
- ·The complete investor list: 13 names
- ·Watch Provivi: the Monday email on marks, rounds and moves
Provivi funding rounds
6 roundsVehicles formed to buy Provivi shares
secondary demand · SEC Form D filingsIn the last 12 months, 2 investment vehicles were formed to buy Provivi shares, reporting $4.7M sold to 54 investors. Most recent filing Mar 2026.
Membership and data by Private Market View
Who backs Provivi
13+Provivi valuation
Provivi's last reported valuation was $420 million in Mar 2021. No priced round, secondary trade or fund mark has surfaced since.
How much has Provivi raised?
Provivi has raised $248 million across 6 recorded rounds since 2013. The largest was an $85 million later-stage round in Jun 2019; the most recent was a $25.5 million early-stage round in Sep 2025.
Provivi has filed 10 Form Ds with the SEC since 2015, most recently in Oct 2019 ($85 million sold to 21 investors).
Institutional holders and vehicles
In the last 12 months, 2 investment vehicles were formed to buy Provivi shares, reporting $4.7 million sold to 54 investors, per SEC Form D filings (most recent Mar 2026).
Provivi investors
13 investors are on record for Provivi, including US National Science Foundation, Temasek Holdings, Gates Foundation and Vivo Capital. The early-stage round in Sep 2025 drew 13 investors.
About Provivi
Developer of insect pheromones designed to protect food supplies without toxic residues. The company's pheromones are designed to create a new foundation for safe, affordable, and sustainable crop protection, enabling farmers to protect crops in a naturally effective and sustainable way.
- Sector
- Materials and Resources
- HQ
- Santa Monica, CA, United States
- Founded
- 2013
- Employees
- 83
- Website
- provivi.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.